| Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra-and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African … H Takahashi, GR Wilkinson, EA Nutescu, T Morita, MD Ritchie, ... Pharmacogenetics and genomics 16 (2), 101-110, 2006 | 486 | 2006 |
| Anticoagulation: low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings EA Nutescu, SA Spinier, A Wittkowsky, WE Dager Annals of Pharmacotherapy 43 (6), 1064-1083, 2009 | 375 | 2009 |
| Drug and dietary interactions of warfarin and novel oral anticoagulants: an update E Nutescu, I Chuatrisorn, E Hellenbart Journal of thrombosis and thrombolysis 31 (3), 326-343, 2011 | 364 | 2011 |
| Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study MA Perera, LH Cavallari, NA Limdi, ER Gamazon, A Konkashbaev, ... The Lancet 382 (9894), 790-796, 2013 | 329 | 2013 |
| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 323 | 2018 |
| Erratum to: pharmacology of anticoagulants used in the treatment of venous thromboembolism EA Nutescu, A Burnett, J Fanikos, S Spinler, A Wittkowsky Journal of thrombosis and thrombolysis 42 (2), 296-311, 2016 | 275 | 2016 |
| Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes AJ Duhl, MJ Paidas, SH Ural, W Branch, H Casele, J Cox-Gill, ... American journal of obstetrics and gynecology 197 (5), 457. e1-457. e21, 2007 | 256 | 2007 |
| Genetic and clinical predictors of warfarin dose requirements in African Americans LH Cavallari, TY Langaee, KM Momary, NL Shapiro, EA Nutescu, ... Clinical Pharmacology & Therapeutics 87 (4), 459-464, 2010 | 246 | 2010 |
| Warfarin and its interactions with foods, herbs and other dietary supplements EA Nutescu, NL Shapiro, S Ibrahim, P West Expert opinion on drug safety 5 (3), 433-451, 2006 | 240 | 2006 |
| Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel S Husted, R de Caterina, F Andreotti, H Arnesen, F Bachmann, K Huber, ... Thrombosis and haemostasis 112 (05), 781-782, 2014 | 193 | 2014 |
| Factors that influence prescribing decisions GT Schumock, SM Walton, HY Park, EA Nutescu, JC Blackburn, JM Finley, ... Annals of Pharmacotherapy 38 (4), 557-562, 2004 | 188 | 2004 |
| Dosing and monitoring of low‐molecular‐weight heparins in special populations BA Duplaga, CW Rivers, E Nutescu Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21 (2 …, 2001 | 185 | 2001 |
| Ezetimibe: a selective cholesterol absorption inhibitor EA Nutescu, NL Shapiro Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (11 …, 2003 | 165 | 2003 |
| Rivaroxaban: an oral direct inhibitor of factor Xa MP Gulseth, J Michaud, EA Nutescu American Journal of Health-System Pharmacy 65 (16), 1520-1529, 2008 | 139 | 2008 |
| Practical management of anticoagulation in patients with atrial fibrillation RJ Kovacs, GC Flaker, SJ Saxonhouse, JU Doherty, KK Birtcher, A Cuker, ... Journal of the American College of Cardiology 65 (13), 1340-1360, 2015 | 132 | 2015 |
| Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum DA Garcia, DM Witt, E Hylek, AK Wittkowsky, EA Nutescu, A Jacobson, ... Annals of Pharmacotherapy 42 (7-8), 979-988, 2008 | 132 | 2008 |
| Decreased Warfarin Clearance Associated With the CYP2C9 R150H (*8) Polymorphism Y Liu, H Jeong, H Takahashi, K Drozda, SR Patel, NL Shapiro, ... Clinical Pharmacology & Therapeutics 91 (4), 660-665, 2012 | 115 | 2012 |
| Implementing pharmacogenomics at your institution: establishment and overcoming implementation challenges MJ Arwood, S Chumnumwat, LH Cavallari, EA Nutescu, JD Duarte Clinical and translational science 9 (5), 233, 2016 | 109 | 2016 |
| Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans K Drozda, S Wong, SR Patel, AP Bress, EA Nutescu, RA Kittles, ... Pharmacogenetics and genomics 25 (2), 73-81, 2015 | 107 | 2015 |
| Real‐world adherence and persistence with direct oral anticoagulants in adults with atrial fibrillation BS Manzoor, TA Lee, LK Sharp, SM Walton, WL Galanter, EA Nutescu Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (10 …, 2017 | 105 | 2017 |
William GalanterDept of Medicine, Univ of Illinois at ChicagoVerified email at uic.edu
